Dopaminergic function and progression of Parkinson's disease: PET findings
Authors:
- R. de la Fuente-FernándezRFR. de la Fuente-Fernández
- 31 December 2009
- journal article
- review article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 15, S38-S40
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Visualizing vesicular dopamine dynamics in Parkinson's diseaseSynapse, 2009
- Imaging of Cholinergic and Monoaminergic Neurochemical Changes in Neurodegenerative DisordersMolecular Imaging and Biology, 2007
- Parkinson's disease: in vivo assessment of disease progression using positron emission tomographyMolecular Brain Research, 2005
- VMAT2 binding is elevated in dopa‐responsive dystonia: Visualizing empty vesicles by PETSynapse, 2003
- In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's diseaseAnnals of Neurology, 2000
- Presynaptic monoaminergic vesicles in Parkinson's disease and normal agingAnnals of Neurology, 1996
- Imaging endogenous dopamine competition with [11C]raclopride in the human brainSynapse, 1994
- Human positron emission tomographic [18F]Fluorodopa studies correlate with dopamine cell counts and levelsAnnals of Neurology, 1993
- Dopa decarboxylase activity of the living human brain.Proceedings of the National Academy of Sciences, 1991
- Dopamine visualized in the basal ganglia of living manNature, 1983